What is Zacks Research's Estimate for Zoetis Q1 Earnings?

Key Points

• Zacks Research has revised its Q1 2027 earnings forecast for Zoetis, predicting earnings per share of $1.67, an increase from the previous estimate of $1.66.
• Zoetis announced a quarterly dividend of $0.50, with the ex-dividend date set for July 18th, indicating a strong commitment to returning value to shareholders.
• Analyst ratings on Zoetis are mixed, with four hold ratings, six buy ratings, and one strong buy, reflecting varied investor confidence.

Zoetis Inc. (NYSE:ZTS - Free Report) - Stock analysts at Zacks Research increased their Q1 2027 earnings per share (EPS) estimates for shares of Zoetis in a research report issued to clients and investors on Wednesday, July 30th. Zacks Research analyst E. Bagri now forecasts that the company will earn $1.67 per share for the quarter, up from their previous forecast of $1.66. The consensus estimate for Zoetis' current full-year earnings is $6.07 per share. Zacks Research also issued estimates for Zoetis' FY2027 earnings at $7.31 EPS.

Several other brokerages have also issued reports on ZTS. Piper Sandler increased their target price on Zoetis from $205.00 to $210.00 and gave the stock an "overweight" rating in a research report on Monday, May 12th. Leerink Partnrs lowered Zoetis from a "strong-buy" rating to a "hold" rating in a research report on Thursday, July 17th. UBS Group decreased their target price on Zoetis from $189.00 to $170.00 and set a "neutral" rating for the company in a research report on Wednesday, May 7th. Leerink Partners lowered Zoetis from an "outperform" rating to a "market perform" rating and decreased their target price for the stock from $180.00 to $155.00 in a research report on Thursday, July 17th. Finally, Stifel Nicolaus lowered Zoetis from a "buy" rating to a "hold" rating and decreased their target price for the stock from $165.00 to $160.00 in a research report on Wednesday, June 18th. Four equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $204.63.

Zoetis Trading Up 1.1%

NYSE ZTS traded up $1.61 on Thursday, hitting $147.40. The company's stock had a trading volume of 3,145,852 shares, compared to its average volume of 3,147,848. Zoetis has a 52-week low of $139.70 and a 52-week high of $200.33. The company has a current ratio of 1.74, a quick ratio of 1.04 and a debt-to-equity ratio of 1.12. The company's 50-day simple moving average is $158.51 and its 200 day simple moving average is $160.46. The firm has a market cap of $65.62 billion, a P/E ratio of 26.46, a PEG ratio of 2.42 and a beta of 0.88.

Zoetis (NYSE:ZTS - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.08. Zoetis had a return on equity of 55.48% and a net margin of 27.12%. The business had revenue of $2.22 billion during the quarter, compared to analysts' expectations of $2.20 billion. During the same quarter last year, the business posted $1.38 EPS. The business's revenue was up 1.4% on a year-over-year basis.

Zoetis Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 3rd. Stockholders of record on Friday, July 18th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date is Friday, July 18th. Zoetis's dividend payout ratio (DPR) is 35.91%.

Insider Activity

In other news, EVP Roxanne Lagano sold 652 shares of the firm's stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $170.00, for a total value of $110,840.00. Following the transaction, the executive vice president directly owned 15,129 shares in the company, valued at $2,571,930. This trade represents a 4.13% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. 0.18% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Zoetis

Institutional investors and hedge funds have recently bought and sold shares of the stock. Brighton Jones LLC increased its holdings in shares of Zoetis by 180.4% in the fourth quarter. Brighton Jones LLC now owns 4,629 shares of the company's stock worth $754,000 after purchasing an additional 2,978 shares during the last quarter. Bank Pictet & Cie Europe AG boosted its holdings in shares of Zoetis by 5.4% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 419,530 shares of the company's stock valued at $68,354,000 after purchasing an additional 21,470 shares during the period. Arrowstreet Capital Limited Partnership raised its stake in Zoetis by 1,269.3% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 267,679 shares of the company's stock worth $43,613,000 after buying an additional 248,131 shares in the last quarter. Schroder Investment Management Group increased its position in shares of Zoetis by 2.6% during the fourth quarter. Schroder Investment Management Group now owns 245,726 shares of the company's stock worth $40,036,000 after purchasing an additional 6,169 shares in the last quarter. Finally, Franklin Resources Inc. lifted its holdings in shares of Zoetis by 6.5% during the 4th quarter. Franklin Resources Inc. now owns 250,152 shares of the company's stock valued at $40,757,000 after purchasing an additional 15,298 shares during the last quarter. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.